PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

New at CPhI Worldwide: Gerresheimer complements its primary packaging portfolio introducing ready-to-fill vials

In hall 4.2 at booth D02 at CPhl Worldwide in Frankfurt, Gerresheimer, a leading global manufacturer of primary packaging for the pharmaceutical industry is presenting the new Gx RTF vials. The customer can receive identically packaged sterile injection vials from two different manufacturers as Gerresheimer’s RTF vials will be delivered adopting Ompi EZ-fill® packaging process.
Two manufacturers – one packaging
Gerresheimer’s two areas of expertise – the glass forming of vials from tubular glass and the ready-to-fill processing of prefillable glass syringes – will also be combined with recognised Ompi EZ-Fill packaging technology for the new Gx RTF vials. The Gx RTF vials are washed, packed in trays or in nests and tubs and sterilised before being delivered to pharmaceutical customers. They can then be filled straight away without the need for any further steps in the process. 
“Our new injection vials meet our customers’ increasing desire for comprehensive solutions. By setting up a standardized packaging platform for sterile vials, we are making the process much simpler for the customer,” says Andreas Schütte, Member of the Management Board for Plastics & Devices at Gerresheimer. 
Flexibility through various packaging configurations
The new product currently exists in the 2R, 6R, and 10R formats in nests and tubs as well as in formats ranging from 4 to 13,5 ml in tray. Further formats will follow. The new packaging solution allows the vials to be used from the development phase of new medications to small or large-scale production.
“We are very happy that Gerresheimer is adopting our leading technology. Our scalable solution gives the customer more flexibility, enhances quality and safety, and reduces time to market”, says Mauro Stocchi, General Manager Pharmaceutical Systems Division of the Stevanato Group. 
Top quality requirements
The Gx RTF injection vials are made from borosilicate glass type I. They meet all established requirements of the applicable ISO standards and pharmacopoeias (USP and Ph. Eur.). By using the Ompi EZ-fill packaging formats, the risk of glass-to-glass contact, which could result in breakages, cosmetic defects, and particle contamination is minimised. 
Expert lecture at CPhl in Frankfurt
Maximilian Vogl, Product Manager Injection Devices in Business Development at Gerresheimer will give a presentation titled “Enhanced flexibility for packaging requirements: Ready-to-fill vials” at CPhl on Wednesday, October 25 at 1:50 p.m. in the Innopack area.   

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026